Top Markets
#1 Black Phoenix Black Phoenix +2,481.31%
#2 Nesa Nesa +757.56%
#3 Ontology Gas Ontology Gas +146.87%
#4 ADO Protocol ADO Protocol +103.33%
#5 Cortex Cortex +95.09%
#6 Kinesis Silver Kinesis Silver +54.45%
#7 Pons Pons +33.01%
#8 Magma Finance Magma Finance +32.06%
#9 OpenEden OpenEden +31.63%
#10 Non-Playable Coin Non-Playable Coin +31.55%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Pacific Edge Limited Pacific Edge Limited

Pacific Edge Limited

PEB
Classifica tra le azioni #18663
Based in Dunedin, New Zealand, Pacific Edge Limited, established in 2001,... Based in Dunedin, New Zealand, Pacific Edge Limited, established in 2001, operates as a cancer diagnostics firm. The company's core mission involves the research, development, and commercialization of advanced diagnostic and prognostic tools aimed at the early identification and ongoing management of various cancers. Its diagnostic solutions are accessible in New Zealand, the United States, Australia, and Singapore, with operations structured across Commercial and Research segments. A key offering is the Cxbladder suite, a collection of genomic urine tests specifically designed for detecting and managing bladder cancer. Within this suite, Cxbladder Resolve aids in identifying patients likely to present with more aggressive or advanced bladder cancer. Cxbladder Triage helps pinpoint individuals with haematuria who exhibit a low probability of bladder cancer, while Cxbladder Detect offers a non-invasive method for identifying bladder and other urinary tract cancers. Furthermore, Cxbladder Monitor facilitates continuous surveillance for disease recurrence in bladder cancer patients. Beyond its focus on bladder cancer, Pacific Edge is actively developing additional diagnostic innovations. These include Cxcolorectal, a prognostic gene signature for assessing outcomes in patients diagnosed with stage II or stage III colorectal cancers, alongside pipeline products targeting gastric, endometrial cancers, and melanoma.
Prezzo delle azioni
$0.15360289
Capitalizzazione di mercato
$190.75M
Variazione (1 giorno)
6.25%
Variazione (1 anno)
94.11%
Paese
NZ
Scambia Pacific Edge Limited (PEB)

Categoria

Healthcare
Margine operativo per Pacific Edge Limited (PEB)
Margine operativo al 2026 TTM: 0.00%
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Pacific Edge Limited, il margine operativo attuale (TTM) è 0.00%. Alla fine del 2026, il margine operativo era 0.00%.
Storico del margine operativo per Pacific Edge Limited da 2026 a 2026
Margine operativo alla fine di ogni anno
Anno Margine Operativo Cambia
Non abbastanza dati per le date fornite.
Margine operativo per aziende simili o concorrenti
Azienda Margine Operativo Differenza del margine operativo Il paese
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
17.69% -
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
20.42% -
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
0.00% -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
-10.70% -
US
Agilent Technologies, Inc. Agilent Technologies, Inc.
Agilent Technologies, Inc.
A.US
21.50% -
US
Cos'è l'Margine operativo di un'azienda?
L'Margine operativo è un indicatore chiave per valutare la redditività di un'azienda. Margini operativi più elevati sono generalmente preferibili poiché indicano che l'azienda riesce a vendere i propri prodotti o servizi a un prezzo significativamente superiore rispetto ai costi di produzione. Si calcola dividendo gli utili per i ricavi.